114 related articles for article (PubMed ID: 30738460)
1. [Expression and Function of miR-99a-5p in Bone Marrow of Patients with MDS].
LE Y; Zhang XP; Xiong YQ; Li HY; Zhao WH; Long Y; Luo J; Cheng P; Liu ZF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):134-140. PubMed ID: 30738460
[TBL] [Abstract][Full Text] [Related]
2. [Expression of miR-550a-5p in Myelodysplastic Syndrome and Its Prediction of Target Genes].
Huang Y; Wen J; Li HY; Zhang XP; Deng DH; Cheng P; Peng ZG; Zhao WH; Luo J; Long Y; Liu ZF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1476-1483. PubMed ID: 27784378
[TBL] [Abstract][Full Text] [Related]
3. [Effect of MiR-99a-5p on the Differential Ability of Human Bone Marrow Mesenchymal Stem Cells].
Xu H; Wang J; Ye X; Ming J; Li SJ; Wang X; He CX; Wang XB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):563-568. PubMed ID: 29665933
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome.
Wen J; Huang Y; Li H; Zhang X; Cheng P; Deng D; Peng Z; Luo J; Zhao W; Lai Y; Liu Z
Int J Hematol; 2017 Jun; 105(6):777-783. PubMed ID: 28224273
[TBL] [Abstract][Full Text] [Related]
5. Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes.
Vasilatou D; Papageorgiou SG; Kontsioti F; Kontos CK; Tsiotra P; Mpakou V; Pavlou MA; Economopoulou C; Dimitriadis G; Dervenoulas J; Pappa V
Leuk Res; 2013 Mar; 37(3):251-8. PubMed ID: 23246221
[TBL] [Abstract][Full Text] [Related]
6. Microarray analysis of differentially expressed microRNAs in myelodysplastic syndromes.
Wan C; Wen J; Huang Y; Li H; Wu W; Xie Q; Liang X; Tang Z; Zhao W; Cheng P; Liu Z
Medicine (Baltimore); 2020 Jul; 99(27):e20904. PubMed ID: 32629683
[TBL] [Abstract][Full Text] [Related]
7. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
[TBL] [Abstract][Full Text] [Related]
8. Biological role and clinical value of miR-99a-5p in head and neck squamous cell carcinoma (HNSCC): A bioinformatics-based study.
Chen YT; Yao JN; Qin YT; Hu K; Wu F; Fang YY
FEBS Open Bio; 2018 Aug; 8(8):1280-1298. PubMed ID: 30087832
[TBL] [Abstract][Full Text] [Related]
9. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
[TBL] [Abstract][Full Text] [Related]
10. Identification of miR-320 family members as potential diagnostic and prognostic biomarkers in myelodysplastic syndromes.
Wan C; Wen J; Liang X; Xie Q; Wu W; Wu M; Liu Z
Sci Rep; 2021 Jan; 11(1):183. PubMed ID: 33420276
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes.
Choi JS; Nam MH; Yoon SY; Kang SH
Leuk Res; 2015 Jul; 39(7):763-8. PubMed ID: 25975751
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome.
Choi Y; Hur EH; Moon JH; Goo BK; Choi DR; Lee JH
Korean J Intern Med; 2019 Mar; 34(2):390-400. PubMed ID: 29132200
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-205-5p is upregulated in myelodysplastic syndromes and induces cell proliferation via PTEN suppression.
Jang SJ; Choi IS; Park G; Moon DS; Choi JS; Nam MH; Yoon SY; Choi CH; Kang SH
Leuk Res; 2016 Aug; 47():172-7. PubMed ID: 27379838
[TBL] [Abstract][Full Text] [Related]
14. [GDF11 level in patients with myelodysplastic syndrome and its clinical significance].
Han Y; Wang H; Fu R; Qu W; Ruan E; Wang X; Wang G; Wu Y; Liu H; Song J; Guan J; Xing L; Li L; Jiang H; Liu H; Wang Y; Liu C; Zhang W; Shao Z
Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(8):620-4. PubMed ID: 26932855
[TBL] [Abstract][Full Text] [Related]
15. [Expression of WT1 and PRAME gene in bone marrow and peripheral blood samples of patients with myelodysplastic syndrome].
Lu D; Qin YZ; Li LD; Shi HX; Lai YY; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):370-6. PubMed ID: 24763007
[TBL] [Abstract][Full Text] [Related]
16. [Biological Characteristics and Risk Factors for Prognosis of Myelodysplastic Syndrome].
Yang YY; Yang JH; Wang D
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1113-1117. PubMed ID: 28823278
[TBL] [Abstract][Full Text] [Related]
17. Identification of microRNA-regulated pathways using an integration of microRNA-mRNA microarray and bioinformatics analysis in CD34+ cells of myelodysplastic syndromes.
Xu F; Zhu Y; He Q; Wu LY; Zhang Z; Shi WH; Liu L; Chang CK; Li X
Sci Rep; 2016 Aug; 6():32232. PubMed ID: 27571714
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-99a-5p in circulating immune cells as a potential biomarker for the early diagnosis of ischemic stroke.
Zhao H; Li G; Ma Q; Tao Z; Wang R; Fan Z; Feng Y; Ji X; Luo Y
Brain Circ; 2017; 3(1):21-28. PubMed ID: 30276300
[TBL] [Abstract][Full Text] [Related]
19. miR-10a-5p, miR-99a-5p and miR-21-5p are steroid-responsive circulating microRNAs.
Li Z; Jiang C; Ye C; Zhu S; Chen X; Wu WK; Qian W
Am J Transl Res; 2018; 10(5):1490-1497. PubMed ID: 29887962
[TBL] [Abstract][Full Text] [Related]
20. miRNA expression profiles in myelodysplastic syndromes reveal Epstein-Barr virus miR-BART13 dysregulation.
Borze I; Scheinin I; Siitonen S; Elonen E; Juvonen E; Knuutila S
Leuk Lymphoma; 2011 Aug; 52(8):1567-73. PubMed ID: 21649547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
